X0306
4
2019-07-01
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001607965
Hindman Andrew A.
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP, Chief Financial Officer
Ordinary Shares
2019-07-01
4
A
0
50000
0
A
50000
D
Share Option (Right to Buy)
16.94
2019-07-01
4
A
0
260000
0
A
2029-06-30
Ordinary Shares
260000
260000
D
This option may be exercised with respect to the first 25% of the shares subject to this option when optionee completes 12 months of continuous service after the Grant Date. This option may be exercised with respect to an additional 1/48th of the shares subject to this option when optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on the 4-year anniversary of the Grant Date provided optionee has remained in continuous service through such date.
Brett A. Grimaud as Attorney-in-Fact
2019-07-03